Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial | MicrobiomeTrials← Back to trialsNCT07632742
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2027-06
Enrollment target: 180 participants Locations- Northwestern University, Chicago, Illinois, United States
Other microbiome trials you might be interested in
Benign Prostate EnlargementBenign Prostate Hypertrophy(BPH)Benign Prostate Obstruction (BPO)
Objectives of the study
The aim of the study is to investigate and compare the treatment efficacy and safety of Oxiblum…
Thessaloniki, GreeceEst. completion Dec 2026
Enlarged Prostate (BPH)Enlarged Prostate With Lower Urinary Tract Symptoms
The objective of this study is to compare a new surgical technique for HoLEP that will allow for sparing of ejaculation …
Chicago, United StatesEst. completion May 2027